Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Mustafa Javaid Kadhim Kadhim Bilal Bawamia Timothy Cartlidge Mohamed Farag Mohammad Alkhalil

Published in: Journal of the American Heart Association (2024)

Omega-3 PUFAs were not associated with increased bleeding risk. Patients receiving high-dose purified EPA may incur additional bleeding risk, although its clinical significance is very modest.

Keyphrases

high dose
atrial fibrillation
low dose
stem cell transplantation